These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 7317951)

  • 1. Macrophage activation for tumor cytotoxicity: control of cytotoxic activity by the time interval effector and target cells are exposed to lymphokines.
    Nakamura RM; Meltzer MS
    Cell Immunol; 1981 Nov; 65(1):52-65. PubMed ID: 7317951
    [No Abstract]   [Full Text] [Related]  

  • 2. Macrophages as effector cells of protective immunity in murine schistosomiasis. IV. Coincident induction of macrophage activation for extracellular killing of schistosomula and tumor cells.
    James SL; Leonard EJ; Meltzer MS
    Cell Immunol; 1982 Nov; 74(1):86-96. PubMed ID: 7159937
    [No Abstract]   [Full Text] [Related]  

  • 3. Macrophage activation for tumor cytotoxicity: characterization of priming and trigger signals during lymphokine activation.
    Meltzer MS
    J Immunol; 1981 Jul; 127(1):179-83. PubMed ID: 7240741
    [No Abstract]   [Full Text] [Related]  

  • 4. Rapid killing of actinomycin D-treated tumour cells by mononuclear phagocytes: reactivity in mouse strains with defective classical tumour cytotoxicity.
    Collota F; Bersani L; Polentarutti N; Mantovani A
    Immunology; 1986 Feb; 57(2):249-53. PubMed ID: 3512426
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tumor-associated transplantation antigen distinct from H-2k-like antigens on a BALB/c (H-2d) fibrosarcoma.
    Parmiani G; Meschini A; Invernizzi G; Carbone G
    J Natl Cancer Inst; 1978 Nov; 61(5):1229-34. PubMed ID: 81882
    [No Abstract]   [Full Text] [Related]  

  • 6. Level of macrophage induction during tumor growth: primed or activated?
    Burger CJ; Elgert KD
    Immunol Commun; 1983; 12(3):285-90. PubMed ID: 6885106
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Macrophages as cytotoxic effector cells.
    Lohmann-Matthes ML; Lang H; Sun D
    Immunobiology; 1982 Apr; 161(3-4):401-7. PubMed ID: 7047379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Natural cytotoxic cells against solid tumors in mice. IV. Natural cytotoxic (NC) cells are not activated natural killer (NK) cells.
    Lattime EC; Pecoraro G; Stutman O
    Int J Cancer; 1982 Oct; 30(4):471-7. PubMed ID: 7141742
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Macrophage tumoricidal activity as a possible antitumor mechanism associated with the local injection of allogeneic spleen cells into rats.
    Kawase I; Komuta K; Namba M; Yokota S; Ogura T; Kishimoto S
    Cancer Res; 1986 Mar; 46(3):1047-54. PubMed ID: 3510719
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Colony-stimulating factors and regulation of macrophage tumoricidal and microbicidal activities.
    Ralph P; Nacy CA; Meltzer MS; Williams N; Nakoinz I; Leonard EJ
    Cell Immunol; 1983 Feb; 76(1):10-21. PubMed ID: 6600975
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Failure of immunogenic tumors to elicit cytolytic T cells in syngeneic hosts.
    Nelson DS; Hopper KE; Blanden RV; Gardner ID; Kearney R
    Cancer Lett; 1978 Aug; 5(2):61-7. PubMed ID: 308390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interferon-gamma is required in activation of macrophages for tumor cytotoxicity.
    Männel DN; Falk W
    Cell Immunol; 1983 Jul; 79(2):396-402. PubMed ID: 6307534
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The macrophage as a cytotoxic effector cell.
    Lohmann-Matthes ML
    Haematol Blood Transfus; 1981; 27():49-57. PubMed ID: 7035303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage activation for tumor cytotoxicity: mechanisms of macrophage activation by lymphokines.
    Meltzer MS; Ruco LP; Leonard EJ
    Adv Exp Med Biol; 1979; 121B():381-98. PubMed ID: 397754
    [No Abstract]   [Full Text] [Related]  

  • 15. Level of activation determines whether inflammatory peritoneal and intratumoral macrophages will promote or suppress in vitro development of cytolytic T lymphocyte activity.
    Gillespie GY; Russell SW
    J Reticuloendothel Soc; 1980 May; 27(5):535-45. PubMed ID: 7373614
    [No Abstract]   [Full Text] [Related]  

  • 16. Activation of tumoricidal properties in macrophages by lymphokines encapsulated in liposomes.
    Fidler IJ; Fogler WE
    Lymphokine Res; 1982; 1(3):73-7. PubMed ID: 6765335
    [No Abstract]   [Full Text] [Related]  

  • 17. Macrophage activation for tumor cytotoxicity: development of macrophage cytotoxic activity requires completion of a sequence of short-lived intermediary reactions.
    Ruco LP; Meltzer MS
    J Immunol; 1978 Nov; 121(5):2035-42. PubMed ID: 712076
    [No Abstract]   [Full Text] [Related]  

  • 18. Macrophage activation for tumor cytotoxicity: regulatory mechanisms for induction and control of cytotoxic activity.
    Meltzer MS; Occhionero M; Ruco LP
    Fed Proc; 1982 Apr; 41(6):2198-205. PubMed ID: 7075791
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine regulation of macrophage effector activities.
    Nacy CA; Belosevic M; Crawford RM; Healy AT; Schreiber RD; Meltzer MS
    Adv Exp Med Biol; 1988; 239():1-11. PubMed ID: 3059762
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Naturally occurring antibodies against fibrosarcoma and glioma cells in rats.
    Itaya T; Moriuchi T; Kodama T; Sendo F; Kobayashi H
    Gan; 1982 Jun; 73(3):454-61. PubMed ID: 7129010
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.